BioRestorative Therapies, Inc. (NV) Share Price
NASDAQ: BRTX | Micro CapBioRestorative Therapies, Inc. (NV) Stock Performance
Open $0.20 | Prev. Close $0.20 | Circuit Range N/A |
Day Range $0.20 - $0.20 | Year Range $0.16 - $1.89 | Volume 104 |
Average Traded $0.20 |
BioRestorative Therapies, Inc. (NV) Share Price Today
As of 30 August 2026, BioRestorative Therapies, Inc. (NV)'s share price is $0.20. The stock opened at $0.20, compared to its previous close of $0.20. During today's trading session, BioRestorative Therapies, Inc. (NV)'s share price traded between $0.20 and $0.20, with an average price of $0.20. Over the past 52 weeks, the stock has recorded a high of $1.89 and a low of $0.16. In terms of performance, BioRestorative Therapies, Inc. (NV)'s share price has declined by 9.32% over the last six months and is down 89.15% on a year-on-year basis.
BioRestorative Therapies, Inc. (NV) Share Price Chart
BioRestorative Therapies, Inc. (NV) Stock Fundamentals & Key Indicators
Market Cap $1.81M | PE Ratio (TTM) -0.13 | Dividend Yield 14.90% |
EPS (TTM) $-1.58 | Revenue (TTM) $359700.00 | Return On Equity (TTM) -3992.21% |
Profit Margin -3959.40% | Debt to Equity 10.44 | Quarterly Earnings Growth YoY -178.38% |
BioRestorative Therapies, Inc. (NV) Quarterly Profit & Loss
All figures in USD
BioRestorative Therapies, Inc. (NV) Annual Profit & Loss
All figures in USD
About BioRestorative Therapies, Inc. (NV)
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. It develops programs relate to the treatment of disc/spine disease and metabolic disorders. The company's products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. It also operates a commercial biocosmeceutical platform. In addition, the company provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
BioRestorative Therapies, Inc. (NV) Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.21 | $0.20 | -0.98% |
Jul 2026 | $0.40 | $0.20 | -45.48% |
Jun 2026 | $0.43 | $0.38 | -17.54% |
May 2026 | $0.22 | $0.46 | +105.41% |
Apr 2026 | $0.27 | $0.22 | -19.27% |
Mar 2026 | $0.21 | $0.28 | +23.87% |
Feb 2026 | $1.17 | $0.22 | -79.82% |
Jan 2026 | $1.20 | $1.10 | -2.65% |
Dec 2025 | $1.06 | $1.13 | +9.18% |
Nov 2025 | $1.44 | $1.03 | -32.79% |
Oct 2025 | $1.43 | $1.54 | +6.21% |
Sep 2025 | $1.74 | $1.45 | -21.83% |
BRTX Share Price FAQs
What is BioRestorative Therapies, Inc. (NV) share price today?
What is the 52 week high and 52 week low of BioRestorative Therapies, Inc. (NV) stock?
What is BRTX's market capitalisation today?
What is BRTX's net income for the last quarter?
What is the 5 year returns of BRTX?
What is the high & low stock price of BRTX today?
Can I buy BRTX shares in India?